EXCELSIOR MEDICAL GETS FDA APPROVAL TO MARKET SWABCAP LUER CAP.
"The luer access valve disinfection process is an important task but one that is, according to research, often subject to non-compliance," states Tony Saia, vice president Global Marketing, Excelsior Medical Corporation. "SwabCap is designed to reduce the risk of contamination by simplifying the disinfection process, while providing standardization to this critical step in the catheter care process."
In addition to SwabCap, Excelsior Medical Corporation expects to launch a second innovation in the coming months - their ZR flush syringe with an integrated SwabCap in a patent-pending flush delivery system.
Excelsior Medical Corporation is the leading manufacturer of pre-filled catheter flush syringes and syringe pump systems. Formed in 1989, Excelsior manufactures, markets, and sells pre-filled saline flush syringes, pre-filled heparin flush and lock syringes, and syringe pump systems to customers in the United States and internationally. Excelsior Medical Corporation is a privately-held company whose main focus is the development of innovative Catheter Maintenance Products that reduce infection, medication errors and healthcare costs.
For more information, visit http://www.excelsiormedical.com. 800/487-4276.
|Printer friendly Cite/link Email Feedback|
|Publication:||Biotech Equipment Update|
|Date:||Jun 1, 2009|
|Previous Article:||EV3 INC. TO EVALUATE SILVERHAWK PLAQUE EXCISION SYSTEM.|
|Next Article:||VARIAN UNVEILS BRACHYTHERAPY APPLICATOR FOR CANCER TREATMENT.|